RGCC announces that on May 21, 2024, acquired “Accreditation Certificate of Foreign Cell Processor” by the Ministry of Health, Labour and Welfare of Japan.

This accreditation certifies that RGCC is a specified cell-processing business operator, certified pursuant to the provisions of Article 39, Paragraph 1 of the Act on Securing, Etc. of Safety of Regenerative Medicine, etc.

Thus, RGCC is ready to start specific processed cell manufacturing and provide contracted cell processing service to medical institutions in Japan.